Research Paper Volume 16, Issue 2 pp 1879—1896
CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers
Figure 8. The relationship between CDK16 and the immune cell infiltration. Correlation between CDK16 and different immune cells from TIMER2 database.